Authors:
de Werra, I
Zanetti, G
Jaccard, C
Chiolero, R
Schaller, MD
Yersin, B
Glauser, MP
Calandra, T
Heumann, D
Citation: I. De Werra et al., CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia, SWISS MED W, 131(3-4), 2001, pp. 35-40
Authors:
Froidevaux, C
Roger, T
Martin, C
Glauser, MP
Calandra, T
Citation: C. Froidevaux et al., Macrophage migration inhibitory factor and innate immune responses to bacterial infections, CRIT CARE M, 29(7), 2001, pp. S13-S15
Authors:
Marchetti, O
Majcherczyk, PA
Glauser, MP
Bille, J
Moreillon, P
Sanglard, D
Citation: O. Marchetti et al., Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles, ANTIM AG CH, 45(3), 2001, pp. 696-700
Authors:
Entenza, JM
Que, YA
Vouillamoz, J
Glauser, MP
Moreillon, P
Citation: Jm. Entenza et al., Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance, ANTIM AG CH, 45(11), 2001, pp. 3076-3083
Authors:
Le Roy, D
Di Padova, F
Adachi, Y
Glauser, MP
Calandra, T
Heumann, D
Citation: D. Le Roy et al., Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria, J IMMUNOL, 167(5), 2001, pp. 2759-2765
Authors:
Meier, PS
Entenza, JM
Vaudaux, P
Francioli, P
Glauser, MP
Moreillon, P
Citation: Ps. Meier et al., Study of Staphylococcus aureus pathogenic genes by transfer and expressionin the less virulent organism Streptococcus goldonii, INFEC IMMUN, 69(2), 2001, pp. 657-664
Authors:
Heumann, D
Adachi, Y
Le Roy, D
Ohno, N
Yadomae, T
Glauser, MP
Calandra, T
Citation: D. Heumann et al., Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxin, INFEC IMMUN, 69(1), 2001, pp. 378-385
Authors:
Calandra, T
Echtenacher, B
Le Roy, D
Pugin, J
Metz, CN
Hultner, L
Heumann, D
Mannel, D
Bucala, R
Glauser, MP
Citation: T. Calandra et al., Protection from septic shock by neutralization of macrophage migration inhibitory factor, NAT MED, 6(2), 2000, pp. 164-170
Authors:
Marchetti, O
Moreillon, P
Glauser, MP
Bille, J
Sanglard, D
Citation: O. Marchetti et al., Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans, ANTIM AG CH, 44(9), 2000, pp. 2373-2381
Authors:
Vouillamoz, J
Entenza, JM
Feger, C
Glauser, MP
Moreillon, P
Citation: J. Vouillamoz et al., Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistantto macrolide-lincosamide-streptogramin B antibiotics, ANTIM AG CH, 44(7), 2000, pp. 1789-1795
Authors:
Marchetti, O
Entenza, JM
Sanglard, D
Bille, J
Glauser, MP
Moreillon, P
Citation: O. Marchetti et al., Fluconazole plus cyclosporine: A fungicidal combination effective against experimental endocarditis due to Candida albicans, ANTIM AG CH, 44(11), 2000, pp. 2932-2938
Authors:
Caldelari, I
Loeliger, B
Langen, H
Glauser, MP
Moreillon, P
Citation: I. Caldelari et al., Deregulation of the arginine deiminase (arc) operon in penicillin-tolerantmutants of Streptococcus gordonii, ANTIM AG CH, 44(10), 2000, pp. 2802-2810
Authors:
Delarive, P
Baumgartner, JD
Glauser, MP
Cometta, A
Citation: P. Delarive et al., Evaluation of antibiotic prophylaxis in neutropenic patients with haematological malignancies, SCHW MED WO, 130(48), 2000, pp. 1837-1844
Authors:
Entenza, JM
Caldelari, I
Glauser, MP
Moreillon, P
Citation: Jm. Entenza et al., Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci, J ANTIMICRO, 44(6), 1999, pp. 775-786
Authors:
Eggimann, P
Francioli, P
Bille, J
Schneider, R
Wu, MM
Chapuis, G
Chiolero, R
Pannatier, A
Schilling, J
Geroulanos, S
Glauser, MP
Calandra, T
Citation: P. Eggimann et al., Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients, CRIT CARE M, 27(6), 1999, pp. 1066-1072
Authors:
Jaccard, C
Troillet, N
Harbarth, S
Zanetti, G
Aymon, D
Schneider, R
Chiolero, R
Ricou, B
Romand, J
Huber, O
Ambrosetti, P
Praz, G
Lew, D
Bille, J
Glauser, MP
Comett, A
Citation: C. Jaccard et al., Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (vol 42, pg 2966, 1998), ANTIM AG CH, 43(3), 1999, pp. 726-726
Authors:
Entenza, JM
Vouillamoz, J
Glauser, MP
Moreillon, P
Citation: Jm. Entenza et al., Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis, ANTIM AG CH, 43(1), 1999, pp. 77-84
Authors:
Le Roy, D
Di Padova, F
Tees, R
Lengacher, S
Landmann, R
Glauser, MP
Calandra, T
Heumann, D
Citation: D. Le Roy et al., Monoclonal antibodies to murine lipopolysaccharide (LIPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS LBP complexes to CD14, J IMMUNOL, 162(12), 1999, pp. 7454-7460
Authors:
Majcherczyk, PA
Langen, H
Heumann, D
Fountoulakis, M
Glauser, MP
Moreillon, P
Citation: Pa. Majcherczyk et al., Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity, J BIOL CHEM, 274(18), 1999, pp. 12537-12543
Authors:
Periard, D
Telenti, A
Sudre, P
Cheseaux, JJ
Halfon, P
Reymond, MJ
Marcovina, SM
Glauser, MP
Nicod, P
Darioli, R
Mooser, V
Citation: D. Periard et al., Atherogenic dyslipidemia in HIV-infected individuals treated with proteaseinhibitors, CIRCULATION, 100(7), 1999, pp. 700-705